ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Immune Thrombocytopenia
Interventions
DRUG

Second Line ITP agents

The treating physicians will select the second line agent and clinical data will be collected.

Trial Locations (29)

10032

Columbia University Medical Center, New York

10065

New York-Presbyterian University Hospital of Columbia and Cornell, New York

19104

Children's Hospital of Philadelphia, Philadelphia

27710

Duke University Medical Center, Durham

30322

Children's Healthcare of Atlanta, Atlanta

38105

St. Jude's Hospital, Memphis

43205

Nationwide Children's Hospital, Columbus

45229

Cincinnati Children's Hospital, Cincinnati

46202

James Whitcomb Riley Hospital for Children, Indianapolis

48236

St. John Hospital & Medical Center, Detroit

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

72202

Arkansas Children's Hospital, Little Rock

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

Texas Children's Hospital, Houston

80045

Colorado Children's Hospital, Denver

90095

Mattel Children's Hospital, Los Angeles

92868

Children's Hospital of Orange County, Orange

94143

UCSF School of Medicine, San Francisco

94304

Lucile Packard Children's Hospital, Palo Alto

94609

Children's Hospital of Oakland, Oakland

95817

UC Davis Medical Center, Sacramento

97239

Oregon Health and Sciences University, Portland

98105

Seattle Children's, Seattle

02115

Boston Children's Hospital, Boston

07960

Goryeb Children's Hospital, Morristown

02903

Hasbro Children's Hospital, Providence

L8S 4K1

McMaster Children's Hospital, Hamilton

KIH8L1

Children's Hospital of Eastern Ontario, Ottawa

H3T1C5

U. de Montreal CHU St. Justine, Montreal

All Listed Sponsors
collaborator

Terrana ITP Research Fund

OTHER

lead

Boston Children's Hospital

OTHER

NCT01971684 - ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP | Biotech Hunter | Biotech Hunter